(-)-Epicatechin protects the intestinal barrier from high fat diet-induced permeabilization: Implications for steatosis and insulin resistance

Redox Biology

Volumn 14, Issue , 2018, Pages 588-599

  Cremonini, Eleonora ^a   Wang, Ziwei ^a   Bettaieb, Ahmed ^b   Adamo, Ana M ^c   Daveri, Elena ^a   Mills, David A ^a   Kalanetra, Karen M ^a   Haj, Fawaz G ^a   Karakas, Sidika ^d   Oteiza, Patricia I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

( ) Epicatechin; Endotoxemia; Insulin resistance; Intestinal permeability; NADPH oxidase; Steatosis

Indexed keywords

APOCYNIN; EPICATECHIN; GLUCAGON LIKE PEPTIDE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; TIGHT JUNCTION PROTEIN; TUMOR NECROSIS FACTOR; CATECHIN; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CACO-2 CELL LINE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DYSBIOSIS; ENDOTOXEMIA; ENZYME ACTIVATION; FATTY LIVER; HEPATITIS; HORMONE BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINE MUCOSA PERMEABILITY; LIPID DIET; LIPID STORAGE; LIVER INJURY; MALE; MOUSE; NONHUMAN; OBESITY; OXIDATION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PROTEIN MODIFICATION; SIGNAL TRANSDUCTION; TIGHT JUNCTION; UPREGULATION; ANIMAL; C57BL MOUSE; DRUG EFFECT; HUMAN; INTESTINE; METABOLISM; PERMEABILITY;

ANIMALS; CACO-2 CELLS; CATECHIN; DIET, HIGH-FAT; FATTY LIVER; HUMANS; INSULIN RESISTANCE; INTESTINES; MALE; MICE, INBRED C57BL; PERMEABILITY; PROTECTIVE AGENTS;

EID: 85034034558     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2017.11.002     Document Type: Article

References (57)

1. Williams, C.D., Stengel, J., Asike, M.I., Torres, D.M., Shaw, J., Contreras, M., et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140 (2011), 124–131.
2. Damms-Machado, A., Louis, S., Schnitzer, A., Volynets, V., Rings, A., Basrai, M., et al. Gut permeability is related to body weight, fatty liver disease, and insulin resistance in obese individuals undergoing weight reduction. Am. J. Clin. Nutr. 105 (2017), 127–135.
3. Bischoff, S.C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.D., Serino, M., et al. Intestinal permeability-a new target for disease prevention and therapy. BMC Gastroenterol., 14, 2014, 189.
4. Geurts, L., Neyrinck, A.M., Delzenne, N.M., Knauf, C., Cani, P.D., Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. Benef. Microbes 5 (2014), 3–17.
5. Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (2007), 1761–1772.
6. Horton, F., Wright, J., Smith, L., Hinton, P.J., Robertson, M.D., Increased intestinal permeability to oral chromium ( Cr) -EDTA in human Type 2 diabetes. Diabet. Med.: a J. Br. Diabet. Assoc., 2013.
7. Piya, M.K., Harte, A.L., McTernan, P.G., Metabolic endotoxaemia: is it more than just a gut feeling?. Curr. Opin. Lipidol. 24 (2013), 78–85.
8. Spruss, A., Kanuri, G., Stahl, C., Bischoff, S.C., Bergheim, I., Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function. Lab. Investig. 92 (2012), 1020–1032.
9. Keita, A.V., Soderholm, J.D., The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol. Motil.: Off. J. Eur. Gastrointest. Motil. Soc. 22 (2010), 718–733.
10. Biasi, F., Leonarduzzi, G., Oteiza, P.I., Poli, G., Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets. Antioxid. Redox Signal. 19 (2013), 1711–1747.
11. Tomas, J., Mulet, C., Saffarian, A., Cavin, J.B., Ducroc, R., Regnault, B., et al. High-fat diet modifies the PPAR-gamma pathway leading to disruption of microbial and physiological ecosystem in murine small intestine. Proc. Natl. Acad. Sci. USA, 2016.
12. Suzuki, T., Hara, H., Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr. Metab., 7, 2010, 19.
13. Harnly, J.M., Doherty, R.F., Beecher, G.R., Holden, J.M., Haytowitz, D.B., Bhagwat, S., et al. Flavonoid content of U.S. fruits, vegetables, and nuts. J. Agric. Food Chem. 54 (2006), 9966–9977.
14. National Cholesterol Education Program National Heart, Lung, and Blood Institute, Third Report of the National Cholesterol Education Program (NECP) Expert Panel on Detection, Evaluation and Treatments of High Blood Cholesterol in Adults (Adult Treatments Panel III) Executive Summary, National Institutes of Health NIH Publication No. 01-3670, May 2001.
15. Shrime, M.G., Bauer, S.R., McDonald, A.C., Chowdhury, N.H., Coltart, C.E., Ding, E.L., Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies. J. Nutr. 141 (2011), 1982–1988.
16. Grassi, D., Desideri, G., Necozione, S., Lippi, C., Casale, R., Properzi, G., et al. Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J. Nutr. 138 (2008), 1671–1676.
17. Davison, K., Coates, A.M., Buckley, J.D., Howe, P.R., Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int. J. Obes. 32 (2008), 1289–1296.
18. Bettaieb, A., Vazquez-Prieto, M.A., Lanzi, C.R., Miatello, R.M., Haj, F.G., Fraga, C.G., et al. (-)-Epicatechin mitigates high fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress. Free Radic. Biol. Med. 72 (2014), 247–256.
19. Cremonini, E., Bettaieb, A., Haj, F.G., Fraga, C.G., Oteiza, P.I., (-)-Epicatechin improves insulin sensitivity in high fat diet-fed mice. Arch. Biochem. Biophys. 599 (2016), 13–21.
20. Bettaieb, A., Cremonini, E., Kang, H., Kang, J., Haj, F.G., Oteiza, P.I., Anti-inflammatory actions of (-)-epicatechin in the adipose tissue of obese mice. Int. J. Biochem. Cell Biol. 81 (2016), 383–392.
21. Vazquez-Prieto, M.A., Bettaieb, A., Haj, F.G., Fraga, C.G., Oteiza, P.I., (-)-Epicatechin prevents TNFalpha-induced activation of signaling cascades involved in inflammation and insulin sensitivity in 3T3-L1 adipocytes. Arch. Biochem. Biophys. 527:2 (2012), 113–118.
22. Contreras, T.C., Ricciardi, E., Cremonini, E., Oteiza, P.I., (-)-Epicatechin in the prevention of tumor necrosis alpha-induced loss of Caco-2 cell barrier integrity. Arch. Biochem. Biophys. 573 (2015), 84–91.
23. Vogiatzoglou, A., Mulligan, A.A., Lentjes, M.A., Luben, R.N., Spencer, J.P., Schroeter, H., et al. Flavonoid intake in European adults (18 to 64 years). PLoS One, 10, 2015, e0128132.
24. Cani, P.D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57 (2008), 1470–1481.
25. Cremonini, E., Mastaloudis, A., Hester, S.N., Verstraeten, S.V., Anderson, M., Wood, S.M., et al. Anthocyanins inhibit tumor necrosis alpha-induced loss of Caco-2 cell barrier integrity. Food Funct. 8:8 (2017), 2915–2923.
26. Aimo, L., Mackenzie, G.G., Keenan, A.H., Oteiza, P.I., Gestational zinc deficiency affects the regulation of transcription factors AP-1, NF-kappaB and NFAT in fetal brain. J. Nutr. Biochem. 21 (2010), 1069–1075.
27. Kleiner, D.E., Brunt, E.M., Van Natta, M., Behling, C., Contos, M.J., Cummings, O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005), 1313–1321.
28. Frese, S.A., Parker, K., Calvert, C.C., Mills, D.A., Diet shapes the gut microbiome of pigs during nursing and weaning. Microbiome, 3, 2015, 28.
29. Zhang, J., Kobert, K., Flouri, T., Stamatakis, A., PEAR: a fast and accurate Illumina paired-end read merger. Bioinformatics 30 (2014), 614–620.
30. Martin, M., Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 17 (2011), 10–12.
31. Caporaso, J.G., Lauber, C.L., Walters, W.A., Berg-Lyons, D., Lozupone, C.A., Turnbaugh, P.J., et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc. Natl. Acad. Sci. USA 108:Suppl 1 (2011), 4516–4522.
32. Mahe, F., Rognes, T., Quince, C., de Vargas, C., Dunthorn, M., Swarm: robust and fast clustering method for amplicon-based studies. PeerJ, 2, 2014, e593.
33. Chao, C.Y., Battat, R., Al Khoury, A., Restellini, S., Sebastiani, G., Bessissow, T., Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: a review article. World J. Gastroenterol. 22 (2016), 7727–7734.
34. Yki-Jarvinen, H., Nutritional modulation of non-alcoholic fatty liver disease and insulin resistance. Nutrients 7 (2015), 9127–9138.
35. Laugerette, F., Alligier, M., Bastard, J.P., Drai, J., Chanseaume, E., Lambert-Porcheron, S., et al. Overfeeding increases postprandial endotoxemia in men: inflammatory outcome may depend on LPS transporters LBP and sCD14. Mol. Nutr. Food Res. 58 (2014), 1513–1518.
36. Harte, A.L., Varma, M.C., Tripathi, G., McGee, K.C., Al-Daghri, N.M., Al-Attas, O.S., et al. High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects. Diabetes Care 35 (2012), 375–382.
37. Amar, J., Burcelin, R., Ruidavets, J.B., Cani, P.D., Fauvel, J., Alessi, M.C., et al. Energy intake is associated with endotoxemia in apparently healthy men. Am. J. Clin. Nutr. 87 (2008), 1219–1223.
38. Gu, Y., Yu, S., Park, J.Y., Harvatine, K., Lambert, J.D., Dietary cocoa reduces metabolic endotoxemia and adipose tissue inflammation in high-fat fed mice. J. Nutr. Biochem. 25 (2014), 439–445.
39. Calabro, V., Piotrkowski, B., Fischerman, L., Vazquez Prieto, M.A., Galleano, M., Fraga, C.G., Modifications in nitric oxide and superoxide anion metabolism induced by fructose overload in rat heart are prevented by (-)-epicatechin. Food Funct. 7 (2016), 1876–1883.
40. Steffen, Y., Gruber, C., Schewe, T., Sies, H., Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch. Biochem. Biophys. 469 (2008), 209–219.
41. Manea, A., Tanase, L.I., Raicu, M., Simionescu, M., Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 396 (2010), 901–907.
42. Zhang, L., Li, J., Young, L.H., Caplan, M.J., AMP-activated protein kinase regulates the assembly of epithelial tight junctions. Proc. Natl. Acad. Sci. USA 103 (2006), 17272–17277.
43. Zheng, B., Cantley, L.C., Regulation of epithelial tight junction assembly and disassembly by AMP-activated protein kinase. Proc. Natl. Acad. Sci. USA 104 (2007), 819–822.
44. Bland, M.L., Lee, R.J., Magallanes, J.M., Foskett, J.K., Birnbaum, M.J., AMPK supports growth in Drosophila by regulating muscle activity and nutrient uptake in the gut. Dev. Biol. 344 (2010), 293–303.
45. Ma, T.Y., Iwamoto, G.K., Hoa, N.T., Akotia, V., Pedram, A., Boivin, M.A., et al. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am. J. Physiol. Gastrointest. Liver Physiol. 286 (2004), G367–G376.
46. Ye, D., Ma, T.Y., Cellular and molecular mechanisms that mediate basal and tumour necrosis factor-alpha-induced regulation of myosin light chain kinase gene activity. J. Cell Mol. Med. 12 (2008), 1331–1346.
47. Suzuki, T., Yoshinaga, N., Tanabe, S., Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium. J. Biol. Chem. 286 (2011), 31263–31271.
48. Al-Sadi, R., Guo, S., Ye, D., Ma, T.Y., TNF-alpha modulation of intestinal epithelial tight junction barrier is regulated by ERK1/2 activation of Elk-1. Am. J. Pathol. 183 (2013), 1871–1884.
49. Moreira, A.P., Texeira, T.F., Ferreira, A.B., Peluzio Mdo, C., Alfenas Rde, C., Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br. J. Nutr. 108 (2012), 801–809.
50. Murakami, Y., Tanabe, S., Suzuki, T., High-fat diet-induced intestinal hyperpermeability is associated with increased bile acids in the large intestine of mice. J. Food Sci. 81 (2016), H216–H222.
51. Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E., et al. A core gut microbiome in obese and lean twins. Nature 457 (2009), 480–484.
52. Mishra, A.K., Dubey, V., Ghosh, A.R., Obesity: an overview of possible role(s) of gut hormones, lipid sensing and gut microbiota. Metab.: Clin. Exp. 65 (2016), 48–65.
53. Alisi, A., Ceccarelli, S., Panera, N., Nobili, V., Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis. Front. Cell. Infect. Microbiol., 2, 2012, 132.
54. Spencer, M.D., Hamp, T.J., Reid, R.W., Fischer, L.M., Zeisel, S.H., Fodor, A.A., Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology 140 (2011), 976–986.
55. Bashiardes, S., Shapiro, H., Rozin, S., Shibolet, O., Elinav, E., Non-alcoholic fatty liver and the gut microbiota. Mol. Metab. 5 (2016), 782–794.
56. Dube, P.E., Brubaker, P.L., Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators. Am. J. Physiol. Endocrinol. Metab. 293 (2007), E460–E465.
57. Baldassano, S., Amato, A., Caldara, G.F., Mule, F., Glucagon-like peptide-2 treatment improves glucose dysmetabolism in mice fed a high-fat diet. Endocrine 54 (2016), 648–656.